drugset
drugset / Trial / NCT01707940

Bioavailability of BI 144807 Given Alone and in Combination With Ketoconazole in Healthy Male Volunteers

NCT01707940 ↗

Phase 1 Completed 24 enrolled Boehringer Ingelheim
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This trial investigates the influence of oral ketoconazole on the pharmacokinetics and safety of BI 144807.

Timeline

Start
2012-10
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketoconazole Small molecule 400 mg Oral
Subject LAZUCIRNON Small molecule — Oral

Indications

No indication recorded.